Warning
Apollo Care Recalls SEMAGLUTIDE 12.5MG (2.5MG/mL)
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0747-2026Drug / Pharmaceutical
Apollo Care Recalls SEMAGLUTIDE 12.5MG (2.5MG/mL)
Apollo Care, LLC · Class II — Moderate Risk
Product Description
SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05
Reason for Recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide within the U.S
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Apollo Care, LLC has recalled a pharmaceutical product that the FDA classified as Class II affecting 56,918 vials. The recall was initiated on July 29, 2026. Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.